The new edition of The Economist has a nice nanotech survey series. Ron Bailey's extensive writing on nanotech includes this piece from October and this feature from our December 2003 issue.
Reason Magazine
Most Popular Stories
- Fox Business Network Cancels Judge Andrew Napolitano's Freedom Watch (2.9)
- Breitbart on libertarians in 2012 (2.11)
- Did the Drug War Make it Any Easier for Whitney Houston to Seek Help For Substance Abuse? (2.12)
- The Inside and Outside of CPAC 2012 (2.10)
- One Possible Reason There Are So Few Liberals, Starring Jonathan Chait. And Some Stuff About Tax Progressivity. (2.10)
Reason RUPE: Public Opinion Survey
- Romney Most Electable Candidate, Yet Gingrich in Statistical Tie Among GOP Voters (1.31)
- Explaining Newt’s Second Surge (1.26)
- George Washington Would Beat Out Romney as Richest President; John Kerry Would Have, Too (1.25)
- New Poll: Americans Aren't Ready for Another War (1.20)
- 2012 Election Match Up: Romney Wins, Paul Might (1.13)
advertisements
Reason on Facebook
Reason on Twitter
Reason on YouTube
Reason RSSGet Reason E-mail Updates!
Manage your Reason e-mail list subscriptionsSite comments/questions:
Media Inquiries and Reprint Permissions:
(310) 367-6109
Editorial & Production Offices:
3415 S. Sepulveda Blvd.
Suite 400
Los Angeles, CA 90034
(310) 391-2245
Editor's Note: We invite comments and request that they be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of Reason.com or Reason Foundation. We reserve the right to delete any comment for any reason at any time.
|12.30.04 @ 2:54PM|#
M$ Passport - RIP:
http://www.msnbc.msn.com/id/6769205/
What else will the anti-M$ crowd think of to hate about M$?
|12.30.04 @ 3:46PM|#
Gary, hitting the New Year's beverages a little early?
One advantage of nanotechnology is the solubility issue. Consider vitamins, that many take and then pee right out. Replacing a 300mg barely soluable tablet with a 3mg one that disolves easily and perhaps binds better is a cost savings to the manufacturer, a more efficient delivery to the body, and a major reduction in the size of the horse pill now offered.
|12.30.04 @ 4:04PM|#
Gary,
Oh, "we" could go on, and on, and on :-). Its patent policy (not by any measure the only or worst offender there, I'm afraid), its FUD campaign against Free/Open Source Software, its extremely expensive software, and its bullying tactics with respect to other software development houses are just a few of the things "we" love to hate.
And then there's the emotionally satisfying activity of kicking the guy at the top, resulting sometimes from jealousy, sometimes indignation, and sometimes schadenfreude.